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Abstract. The paper investigates thresholds and options for financing innovation activities in 
manufacturing and services using data from the German Community Innovation Survey (CIS) 
2007. We analyze the significance of financing restrictions, especially the role of internal 
financing, external capital, and public funding, and discuss applicable management options to 
cope with challenges in markets and technology. We find that most firms rely mainly on self-
financing means to start an innovation project. As a consequence of information asymmetries, 
private investors, e.g. banks, are uneager to invest in risky innovative ventures. Public funding 
might complement internal financing in order to balance shortcomings in private capital 
provision, but these sources have to be identified and convinced. In sum, the empirical work 
states that financing innovation is an entrepreneurial task, and the management of innovation 
needs strategic thinking as well as a well defined capital portfolio policy.  
 




1. Funding as an obstacle to innovation 
 
It is generally accepted that growth in modern economies is based on efforts to 
increase productivity by innovation (BMBF, 2007). Innovation is an essential 
precondition for technological and structural changes, contributing to growth and 
competitiveness. At the firm level, innovation is a form of entrepreneurial risk-taking 
(Drucker, 1985; Tidd et al., 2005). Introducing new products, entering new markets, 
increasing efficiency, or improving quality involves investments in research 
infrastructure and people. Innovation management means not only the operational 
control of processes, but also the strategic management of the firm. A fundamental 
component of strategic innovation management is the long-term decision to innovate, 
which is accompanied by the need to establish structures and to provide resources for 
the acquisition of technology. 
Factors hampering innovation curtail the profitability of innovative projects, 
and are an indication that framework conditions are acting to reduce the extent of 
innovation activities in the national economy. They may lead firms not to start 
innovation activities at all, or be reasons for a delay of or even an unsuccessful end to Management & Marketing 
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innovation projects. Generally, factors which constitute barriers to innovative success 
can be put into the following categories: 
  Costs, economic risks and profit opportunities; 
  Lack of internal and external funds; 
  Knowledge and human capital; 
  Legal and bureaucratic burdens; 
  Intra-firm restrictions and resistance. 
Reviewing the obstacles to innovation activities that firms in manufacturing 
and services in Germany experienced as a hampering factor of relevance and 
importance a number of interesting results occur (Rammer and Weißenfeld, 2008; 
Aschhoff et al., 2007): Firstly, excessive risks and substantial costs of innovation 
projects can be regarded as the main barriers to innovation. A large amount of capital 
must be invested in the innovation process, yet it is difficult to estimate at the 
beginning of the innovative activity whether and when it will pay off and what 
economic effects it may have. Secondly, sourcing, allocating and funding the 
necessary resources, such as equipment, personnel and know-how can often present 
considerable difficulties carrying out innovation activities. Firms in manufacturing 
and services may be affected by a lack of an appropriate internal source of finance. At 
third, unsurprisingly, the importance of innovation obstacles, especially the challenges 
of funding goes hand in hand with the size of the firm. Small and medium-seized firms 
(SMEs) find it harder to overcome the financial limitations, particularly because of 
high fixed costs, minimum investments needed to start innovation projects and high 
information asymmetries at the side of external financers. As a consequence, the 
likelihood that SMEs extend, abort, or do not initiate an innovation project is higher in 
comparison to larger firms.  
Getting access to sufficient financial sources is one of the main challenges in 
innovation. In general, firms have more ideas for technically feasible and customer 
demanded innovation than they can fund with the resources at hand (Peeters and van 
Pottelsberghe, 2003). Financing restrictions thus reduce the volume of innovation 
activities of firms. On the one hand, such financing restrictions are unavoidable and 
serve as a way to allocate scarce resources to those projects that promise the highest 
returns. On the other hand, there are indications that firms invest less into innovation 
than would be necessary to maximize social returns (Hall, 2005).  
From the financing side, two factors contribute to underinvestment in 
innovation: First, many innovation projects show an unfavorable ratio between 
earnings and costs due to a low exclusive appropriability of innovation returns 
(Arrow, 1962). From a firm perspective, such risky projects show too high innovation 
costs. Intellectual property rights (IPRs) are the main government instrument to ensure 
full appropriability for the innovator and thus improve the cost-earning-ratio of 
innovation, though for a number of innovative activities, no effective IPRs exist. Financing of innovations – thresholds and options 
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Secondly, suppliers on financial markets, especially banks, are reluctant to finance 
innovative activities of firms, resulting in a low supply of loans for innovation 
financing. There are many reasons for this reluctance (Hall, 2005), such as information 
asymmetries, moral hazard, adverse selection and lack of collaterals.  
As a consequence, innovative firms are often forced to rely on internal funding 
sources for innovation (cash flow financing). Other sources of private capital are 
offered outside the firm (external equity financing) such as private equity, venture 
capital, and stock markets. Due to the specific terms of the agreement these financial 
means are of minor attractiveness, especially for SMEs. As an alternative to private 
funds, firms can receive public support for R&D and innovation. Public financial 
sponsorship of innovation projects is given as grants, loans, subsidies, or credit 
guarantees.   
When firms are asked to state which sources of funding were employed to 
finance innovation projects, data on German firms for the time period 2004 to 2006 
reveal the following picture (Annex,  Table 1)(Community Innovation Survey, 2007):  
  Firstly, the huge majority of firms (87%) finance innovation projects out of 
funds generate by ongoing business operations, such as profits, sales, working capital, 
or extended payment terms (cash flow financing). Some 95 percent of enterprises in 
high-tech production and almost 80 percent in knowledge-intensive services utilize 
internally generated financial means for innovation activities; 
  Secondly, debt financing by using credit lines and current account 
advances is the second important means of funding for enterprises in manufacturing 
and services. Almost 20 percent of firms in high-tech production, especially SMEs, 
and 19 percent in knowledge-intensive services utilize these relatively unprofitable 
financing instruments. Standard bank loans are ranked on place number three. Credit 
financing implies a couple of disadvantages for firms, e.g. dependency on lender, high 
interest rates, and concerns about the securities;  
  Thirdly, other private funding sources that are external to a firm are stock 
markets and private equity funds are sought. The empirical data reveal that the 
admission of new shareholders, participation of other enterprises, shareholders’ loans, 
dormant equities, and/ or participation certificates have a similar importance as bank 
loans but play a minor role compared to internal funding;  
  Finally, in addition to internal and private external capital, firms may 
obtain public money either through loans or allowances and grants to develop and 
launch innovations. On average, 11 percent of all firms utilize public subsidies for 
financing innovation projects, and 5 percent absorb public loans. 
The data clearly show that firms first of all rely on their self-financing power 
and use sources such as profits or reserves out of ongoing business operations. 
External funding sources are of minor importance and in most cases complementary to 
cash flow. Neither bank loans or current account advance (credit lines) nor public 
loans or subsidies are utilized to finance innovation projects to the same extent as cash Management & Marketing 
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flow financing. Internal financial means are thus an absolutely essential precondition 
to finance innovation projects. Without cash flow or other reserves it is often 
impossible to acquire additional financial sources outside the firm. 
 
2. Empirical analysis of financing of innovation 
 
2.1. Theoretical Framework and Considerations 
 
The challenge of financing innovation is very much associated with the type of 
innovation being performed in a sector. Innovation financing will become the more 
difficult the larger a project, the higher the risks of technology, market, and 
implementation, the longer the project duration, and the lower the volume of available 
collaterals (Hall 2005). With respect to loan funding - which is in general the most 
important external funding source for investment in firms - risk exposure and 
collaterals are the two most important factors: A high risk increases the asymmetry 
between lender and borrower since high-risk projects are more likely to fail, 
threatening the lender with a total loss of money. Low collaterals in innovation 
projects occur in case of predominating intangible investment, such as expenditure for 
R&D, skill formation and design while a high share of gross fixed capital formation 
(i.e. capital expenditure) in total innovation expenditure indicates high collaterals 
available for securing loans. 
Another important determinant for choosing funding sources for innovation is 
the type of innovation project pursued, particularly with respect to its risk exposure. 
Risk in innovation has basically two dimensions: On the one hand, an innovation may 
fail because of technological problems. These are likely to increase with the degree of 
technological novelty and sophistication. In case a completely new technological path 
is taken, firms can not rest on past experiences and may be confronted with 
unanticipated challenges which may increase costs, prolong project durations or even 
call for a termination of the project. On the other hand, market acceptance is another 
source of innovation risk, particularly if firms enter markets they are not familiar with. 
With regard to product innovation, one may distinguish four types of risk exposure, as 
can be seen in Overview 1:  
  Incremental innovations, i.e. innovations that are linked to existing 
products and serve to improve, extend or complete them. They are neither new to the 
market nor new to the firm’s range of products and/or business area; 
  Market novelties (without a previous version on the market, but a 
comparable product within a firm’s product range) are innovations that are new to the 
market and represent an expansion of or a complement to an existing product line, but 
do not increase the breadth of a firm’s range of products and/or business area meaning 
that they are introduced on a market the firm is familiar with; Financing of innovations – thresholds and options 
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  Product range novelties (without a previous version within the firm, but a 
comparable product on the market) are innovations that are new to the firm in that they 
expand the firm’s range of products and/or business area. This is typically associated 
with entering a market that is new to the firm. The innovation need not be new to this 
market, however, since other firms may already offer comparable products with the 
same intended use; 
  Radical product innovations combine market novelties and product range 
novelties, i.e. with these innovations a firm both enters a new market and introduces a 
product on this market which has not been offered by any other firm before. 
The idea behind this typology according to the level of innovation is that a 
firm has certain „thresholds” in its innovation process. These thresholds affect the way 
innovation is planned, organised, operated, and financed, because they imply different 
forms of uncertainty and risk. 
 
Overview 1 









The innovation is new 





innovation  Product range novelty 
   No  Yes 
   The innovation widens the firm’s range of products 
and/or business area  
 
It can be assumed that in order to bring out innovations that are new to the 
market and/or sector (market novelties and radical product innovations), firms have to 
go beyond a „technological threshold”, while in the case of innovations, which expand 
a firm’s range of product and/or business areas (product range novelties), they are 
confronted with a „market threshold”.  
Radical innovations promise suitably lucrative returns. Since this type of 
innovation involves pushing technology beyond its current boundaries and developing 
a marketing concept for a new target group. Firms that demonstrate this kind of 
product innovation are venturing into undiscovered territory in terms of technology 
and the target market and tend to be confronted with the highest costs and levels of 
uncertainty. Not only the adoption but also the application of technology is a 
challenging task in the product development process. In association with the 
generation of technical competence marketing concepts and strategies for the 
successful entry and penetration onto a market must be developed. 
The introduction of product range novelties involves less uncertainty, since the 
firm can – as a follower in the market – refer back to the experiences of other firms. 
The difficulties in building up a new product line lie in passing the market threshold Management & Marketing 
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since the firm must catch up with its competitors and establish itself in a market that is 
new to it. Product range novelties involve less technological risk since the technology 
has typically been tested to some extent and that the market for the product already 
exists. Still, in this situation some risks remain: within the firm due to a likely internal 
resistance and the need to reorganise routines, and related to competition when dealing 
with market entry barriers. 
Summing up, it is to be expected that overstepping the technology threshold 
(market novelties and radical innovations) will involve more technological and market 
risk than is the case for product range novelties and incremental innovation, the main 
requirement of which lies in marketing efforts and organisational adaptation. 
Additionally, it is obvious that financing projects within the range of incremental and 
radical product innovation requires strategic thinking, a decision which degree of 
innovativeness should be achieved, and a target-oriented financial policy. 
The degree of novelty and risk that is captured by this classification of new 
products may be extend by another dimension which is related to research and 
development (R&D) efforts. Firms that introduce new products based on own R&D 
efforts may indicate a higher level of sophistication with respect to the technology 
involved in new products, and thus experience higher (technological) uncertainty. 
Not all innovation activities refer to product innovation. A significant fraction 
of firms focus their innovative efforts on new or improved processes. For process 
innovation, the level of market risk and technological uncertainty is generally lower. 
On the one hand, firms may rest on technology suppliers and their experience when 
implementing new processes. On the other hand, process innovation often affects the 
way an already existing product which is well established on the market is produced. 
The role of market uncertainty is thus significantly smaller. Nevertheless it is 
worthwhile to distinguish two types of process innovation: efficiency innovations 
(intended to decrease unit costs of production) and quality innovations (intended to 
increase a product’s quality or performance characteristics). With regard to efficiency 
innovation, their might be a higher degree of technological uncertainty since it raising 
efficiency of processes will involve new production methods or technological changes 
in existing ones. Positive effects of quality innovation have to be gained on the market 
through raising sales of profit margins which naturally is associated with some market 
risks, e.g. whether customers are willing to pay more for higher product quality. 
Combining both types constitute a “radical” process innovation while new processes 
that neither result in higher efficiency nor improved quality may constitute 
„incremental” process innovations. 
 
2.2. Empirical analysis  
 
The following part investigates the interdependence between the 
characteristics of innovations as described above and the financial sources used to 
fund these innovations. The points of interest are the driving factors that determine a Financing of innovations – thresholds and options 
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firm’s decision to use a certain source given the risk exposure of the innovation 
project. In the course of the examination, a better understanding of a firm’s financial 
portfolio policy with regard to innovation activities should be achieved. The following 
hypotheses guide our analysis: 
  The higher the risk exposure of an innovation due to technology, market, 
or implementation (organization) the higher is the probability that innovation projects 
are predominantly financed by self-financing means (cash flow); 
  The higher the risks of innovation due to technology, market, or 
implementation (organization) the less external private capital in terms of bank loans 
is utilized; 
  The higher the technological risks of innovation projects the higher is the 
probability that public money can be acquired to finance innovation. 
In order to test these hypotheses, we conduct multivariate analyses. Our 
dependent variable which should be explained is the information whether a firm has 
made use of a certain type of financial source to fund its innovation projects. This 
information is binominal, i.e. we only know whether a source has been used or not 
during a certain period of time, but we do not know the amount of money that has 
been allocated. Given this data quality we apply a probity model approach (Maddala, 
1983). The decision of a firm i to use a financing source F of type j for funding 
innovation activities is modelled as a function of a vector I of innovation 
characteristics and a vector X of control variables (such as size, age, sector, location). 
The latent model is given by 
 
    
 
with  being a constant term,  and  vectors of parameters and  a firm-specific error 
term which is assumed to be iid (0;). The probability to use a finance source of 
type j (F*ij) cannot be observed completely but only as a binary choice 
 
 1  if  F*ij > 0 
Fij =     [2] 
 0  if  F*ij ≤ 0 
 
We thus use Fij as dependent variable in out model. In order to simplify the 
analysis, we only look at three financing sources out of the eight shown in Annex, 
Table 1: cash flow, bank loans and public subsidies since these represent three clearly 
distinguished types of financing. 
A multitude of factors may influence a firm’s decision of how to finance an 
innovation project. Some factors are directly related to the innovation process and 
management behavior. Other determinants are straightforwardly linked to the financial Management & Marketing 
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opportunities and resources of the firm, the economic and technological resources at 
hand, and the legal scope. The following groups of indicators are distinguished: 
  Innovation activities are characterized by the type of product innovation 
and the type of process innovation according to the classification discussed in the 
previous section, as well as by a dummy variable whether a firm conducts in-house 
R&D on a continuous base (as an indicator for the efforts to generate new technology). 
Furthermore, we calculate the share of capital expenditure in total innovation 
expenditure as a proxy for the amount of collaterals available to secure external 
capital. Capital expenditure includes fixed investment and investment in intangibles 
such as patents, trade marks or software; 
  Another set of indicators represent the capabilities of internal financing 
and liquidity and capital resources. The equity ratio (equity as a share of total assets) 
informs about the ability of a firm to back external capital by own funds. We also use 
dummy variables on the direction of change of the equity ratio between 2004 and 2006 
since a decrease (increase) may signal external capital providers a worsened 
(improved) internal financing situation. The profit margin indicates the amount of 
internal funds available for financing future investment and enters the model as a 
lagged variable; 
  Furthermore, we include firm characteristics such as size, age, sector 
affiliation and location (differentiating between East and West German firms). Since 
financing opportunities of firms may depend on their legal status, we add dummy 
variables on the legal form and whether a firm is predominantly owned by private 
individuals or a family (which may enable the firm to profit from the personal wealth 
of these individuals). We also control for a firms affiliation to an enterprise group, 
differentiating by domestic and foreign ownership. 
Altogether, these factors are assumed to influence a firm’s decision making 
process and consequently the budgeting policies of innovation projects. Not only 
persons in charge inside a firm who run the management of innovation take these 
indicators into account, but also external executives, experts in banks and public 
institutions value their decision on base of these elements. 
All variables are taken from the German CIS conducted in 2007. The 
dependent variables refer to innovations projects conducted between 2004 and 2006, 
though the actual information provided by firms on the funding source used to finance 
these innovative efforts is rather biased to the most recent activities. Innovation 
characteristics refer to the same reference period, while equity ratio is available for 
2006 only. Profit margins are for 2005, while all control variables present the situation 
of the year 2006. A total of 2,013 observations with full information on all model 
variables are available. Note that only firms with innovation activities conducted 
during 2004 and 2006 enter the model. While most of them successfully introduced 
either product or process innovation, there is a small fraction of firms with innovation 
activities, but no successful innovation (e.g. having introduced a new product on the 
market or a new process within the firm) were implemented by the end of 2006. Financing of innovations – thresholds and options 
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2.3. Results of the Analysis  
 
The estimation results of three separate probity models are reported in Annex, 
Table 2. They reveal that the financing of radical product innovations and product 
range novelties show a higher impact on the probability to use self-financing 
opportunities (cash flow) while financing through bank loans is rarely considered by 
firms conducting in-house R&D on a permanent base or introducing radical product 
innovations. The explanation for this result is twofold: first, external investors have 
only little interest to put money in risky and uncertain innovation projects. R&D 
activities as well as innovation projects that are characterized by a high degree of 
novelty (radical product innovations) imply technical, economical, and organisational 
risks that are difficult to assess from outside the firm. Secondly, the utilisation of 
internal financial resources is the easiest and fastest way to allocate funds to 
innovation projects. There is no dependency of the lender, no duty to repay interest, 
no participating of others in the decision making process, no divulgement of relevant 
data and information. Due to these reasons self-financing is the natural and 
entrepreneurial way of financing innovation projects. The higher the degree of 
innovativeness, the more important is this source, as long as product innovation in 
concerned.  
The negative impact of in-house R&D on the probability to use bank loans 
may be related to different concerns on the lenders side of the transaction. The 
negative attitude of banks has clearly to do with the above mentioned high uncertainty 
over the outcome of R&D activities. Banks typically have problems to assess the 
technological and organisational operations associated with in-house R&D. Not only 
the adoption but also the application of technology is a challenging and risky task in 
the product development process. Furthermore, collaterals are missing which are 
demanded by internal controlling mechanism of banks and/or regulation authorities. 
Finally, there is an implicit suspiciousness against the ability and competence of the 
borrower.  
However, process innovations are more attractive investments for commercial 
banks. Banks fund different types of process innovation in a similar way, i.e. not 
discriminating between incremental, efficiency-oriented or quality-oriented process 
innovations. One obvious reason is that process innovations are less subject to 
information asymmetries since it is easier for a bank to assess the involved risk and 
the likely outcome since many process innovations are similar among firms and rely 
on standard technologies. It is thus easier to calculate the likely returns of such 
innovation projects and their periods of amortisation. Investors seek for facts and 
figures that are reliable and on which they can proof the economic benefits of the 
innovation project. A comprehensible outline of the whole innovation process, a 
precise description of the purpose of the new product, the unique selling proposition, Management & Marketing 
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and the advantages for the customers, together with the planned actions to reach a 
targeted position in competition are necessary requirements in convincing external 
investors. What is more, process innovations are more likely to offer collaterals for 
loans. 
The use of public subsidies for financing innovation is highly correlated with 
R&D activities and market novelties that open up a new market (radical innovation). 
Firms conducting in-house R&D on a permanent base show an 8 percentage points 
higher probability to finance innovation through public money, and introducing 
radical product innovation increases the probability of using public subsidies by 5 
percentage points. This result reflects the government’s goal to use public funding for 
generating radical innovations that contribute to growth and employment. This is most 
likely the case with market novelties. Since generating market novelties most often 
involves the development of new technology as a prerequisite, there is also a strong 
effect of R&D. With regard to process innovation, quality innovations tend to be 
financed more likely through public subsidies. This reinforces the finding for product 
innovations, since quality innovations are that type of new processes that are most 
likely associated with employment growth (through an increase in sales due to the 
improved product quality). 
The financial variables basically show the expected signs. Profit margin exerts 
a strong positive impact on the use of cash flow, as does a high equity ratio and an 
increase in the equity ratio over the past years. A firm’s past profitability has almost 
no effect on using bank loans for funding innovation, however. Interestingly, firms 
with a low equity ratio are more likely to use bank loans. This result may reflect that 
firms with a high equity ratio have sufficient self-financing means and thus refrain 
from asking for credit financing. Credit financing does not only imply concerns on 
side of the lender (see above), it is a source of innovation financing that contains also a 
couple of disadvantages for the borrower. There is the dependency on lender, the 
payment of potentially high interest rates, the concerns about the possible disclosure 
of critical firm data, and doubts about the securities to be provided. Firms with high 
profit margins are less likely to finance innovation through public subsidies. An 
explanation for this finding may be the government’s tendency to focus public funding 
on those firms that need it most. On the other hand, firms with high profits will have 
sufficient in-house funds and do not need to apply for public funding, which is 
associated with significant transaction costs due to complex application procedures 
and rather long decision making processes at public agencies.  
There are also some effects of firm characteristics on financing decisions. 
Large firms are more likely to use cash flow or public subsidies, while family-owned 
firms tend to use bank loans more often and show a lower propensity to use public 
money. Firms that are part of an enterprise group are less likely to receive public 
funding (or refrain from applying for it). The legal status of a firm as well as its age Financing of innovations – thresholds and options 
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both exert little effects on innovation financing decisions, except from a lower 
propensity of corporate enterprises to use bank loans. 
 
3. Conclusion: managing thresholds and finance   
 
Summing up, for the majority of firms financing innovation activities is an 
undertaking during which a number of problems arise. The specific economic 
characteristics of innovation projects (risk and uncertainty, information asymmetries, 
moral hazard, lack of collateral) discourage institutional investors from investing in 
innovative projects.  
Firms thus have to rely on their own financial means to start innovation 
projects. Financing innovation by allocating a part of current operation profits to 
activities is fraught with risks. If successful, cash flow financing will not create 
revenue until later periods. Since most of this investment is in current expenditure 
(salaries, material, external services), financing of innovation projects drains the 
current operating profit and can severely restrict an enterprise’s liquidity. The negative 
cash-flow effects tend to affect firms seriously and might lead to an underinvestment 
in innovation that would be necessary to fulfill the challenges in highly competitive 
markets. 
A firm, especially a small or medium-sized one, needs to consider available 
sources of finance very carefully. The choice of debt or equity financing depends on a 
variety of factors, because all financial means have advantages and disadvantages. In 
the innovation process a firm’s financial ability - in particular the internal financing 
capacity – is of uppermost importance. A firm that receives private equity or bank 
loans has to accept some loss of control, strong financial discipline, and sharing the 
profits respectively paying interest. The primary purpose of every lender is the 
creation of value and profit, i.e. sustained growth and a satisfactory return on the 
investment. Firms can sometimes obtain public money to develop and launch an 
innovative idea. Public money cannot remove risk from the innovation activities at the 
firm level, but it can endeavor to make the innovation scenario more attractive. 
Governments put schemes in place to encourage banks and other private investors to 
award loans to what they might otherwise consider undesirable customers, especially 
high risk ventures in small firms. Going beyond technology and marketing thresholds 
at the same time the empirical work suggests a mix of sources, especially cash flow, 
and public funds. 
Management has to understand the economics of valuation of innovation 
activities in order to attract potential investors, such as banks, venture capitalists, and 
public authorities. Managers have to think entrepreneurial, primarily to check market 
opportunities and technology trends. They are responsible for the innovation strategy 
and set the goals of the product development process. Aiming to cross thresholds in Management & Marketing 
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technology and marketing needs furthermore an appropriate portfolio management of 
financial resources. The willingness to take risks in the development of new products 
and technologies are core business characteristics which can not substituted by any 




Arrow, K.J. (1962), Economic Welfare and the Allocation of Resources for Invention In 
Nelson, R. (Ed.): The Rate and Direction of Inventive Activity, Princeton: Princeton 
University Press, pp. 609-626 
Aschhoff, B., Blind, K., Ebersberger, B., Fraaß, B., Rammer, C., Schmidt, T. (2007), 
Schwerpunktbericht zur Innovationserhebung 2005, ZEW Dokumentation no. 07-03, 
Mannheim. 
BMBF (2007), 2007 Report On The Technological Performance of Germany, Summary, 
Bundesministerium für Bildung und Forschung, Berlin. 
Czarnitzki, D. (2006), Research and development in small and medium-sized enterprises: the 
role of financial constraints and public funding, Scottish Journal of Political Economy, 53, 
pp. 335-257 
Drucker, P. (1985), Innovation and Entrepreneurship, New York: Harper & Row 
Goodacre, A., Tonks, I. (1995), Finance and Technological Change. In Stoneman, P. (Ed.): 
Handbook of the Economics of Technological Change, pp. 298-341, Oxford: Basil 
Blackwell 
Grabherr, O. (2003), Finanzierung mit Private Equity und Venture Capital. In Kofler, G., 
Polster-Grüll, B. (Eds.) Private Equity und Venture Capital, pp. 219-264, Wien  
Hall, B.B. (2006), The Financing of Innovation. In Shane, S. (Ed.), Blackwell Handbook of 
Technology and Innovation Management, Oxford: Blackwell 
Herstatt, C., Verworn, B. (2003), Bedeutung und Charakteristika der frühern Phasen des 
Innovationsprozesses. In Herstatt, C., Verworn, B. (Eds.) Management der frühen 
Innovationsphasen, pp. 3-15, Wiesbaden: Gabler 
Himmelberg, C.P., Petersen, B.C. (1994) R&D and Internal Finance: A Panel Study of Small 
Firms in High-Tech Industries, The Review of Economics and Statistics, 76, pp.  38-51 
Kortum, S., Lerner, J. (2000), Assessing the contribution of venture capital to innovation, 
RAND Journal of Economics, 31, pp. 674-692 
Maddala, G.S. (1983), Limited-Dependent and Qualitative Variables in Econometrics, 
Cambridge: Cambridge University Press 
Peeters, C., Pottelsberghe, B. van (2003), Measuring innovation competencies and 
performances: a survey of large firms in Belgium, Institute of Innovation Research Working 
Paper, Hitotsubashi University, pp. 3-16 
Peters, B., Rammer, C., Binz, H. (2006), Innovationsfinanzierung: Stand, Hindernisse, 
Perspektiven. In KfW (Ed.), Mittelstands- und Strukturpolitik. Sonderband "Innovationen 
im Mittelstand", pp. 95-147, Frankfurt/Main: KfW-Bankengruppe Financing of innovations – thresholds and options 
 
15
Rammer, C., Weißenfeld, B. (2008), Innovationsverhalten der Unternehmen in Deutschland 
2006. Aktuelle Entwicklungen und ein internationaler Vergleich, Studien zum Deutschen 
Innovationssystem, no. 04, Berlin: BMBF 
Rammer, C., Peters, B., Schmidt, T., Aschhoff, B., Doherr, T., Niggemann, H. (2005), 
Innovationen in Deutschland. Ergebnisse der Innovationserhebung 2003 in der deutschen 
Wirtschaft, ZEW Wirtschaftsanalysen 78, Nomos, Baden-Baden. 
Tidd, J., Bessant, J., Pavitt, K. (2005), Managing Innovation. Integrating Technological, 
Market and Organizational Change, 3rd edition, Chichester: Wiley 







Financial sources used for financing innovation by innovative enterprises  
in Germany (2004-2006, %) 
 
  A B C D E F G H 
Sector (Nace rev. 1.2)          
10-14  88  0 0 0 27  19  2 6 
15-16 92  1  14  0  37  20  8  9 
17-19  96  1 10  0 11  9 7 17 
20-22  91  8 15  3 21  9 7 8 
23-24  95  8 16  0 20  7 7 14 
25 94  6  10  1  24  14  5  19 
26  77 13 12 0  12 16 17 11 
27-28  94 3  10 0  21 20 14 15 
29  96  2 8 0 18  18  9 15 
30-32  98  9 12  0 25  8 3 19 
33  91 12 15 1  34 10 8  20 
34-35 84  6  16  1  16  14  9  12 
36-37  82 12 22 0  25 18 17 6 
40-41  90  2 7 0 13  14  7 3 
51 87  4  23  0  39  35  1  7 
60-63,  64.1  86  1 8 1 30  17  5 3 
65-67  95  5 3 0 4 0 0 0 
72,  64.3  96  5 20  1 25  2 1 17 
73,  74.2-74.3  78  15  17  0 20  4 9 32 
74.1,  74.4  75 18 28 0  17 17 3  3 
74.5-74.8, 90  96  5  13  0  16  16  4  4 
92.1,  92.2  88  3 19  0 14  4 11  11 
Sector group          
High-tech production  95  6  12  0  22  13  7  16 
Low-tech  production  91 5  13 1  22 15 10 12 
Knowledge-intensive  services  81 14 22 0  19 10 4  13 
Other services  89  3  16  0  30  25  3  5 
Size class (# employees)          
5 to 49  85  9  19  0  24  16  5  10 
50 to 99  92  6  11  1  20  20  7  16 
100 to 499  93  5  9  1  21  13  8  12 
500 and more  92  4  4  1  12  11  7  13 
Region          Financing of innovations – thresholds and options 
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  A B C D E F G H 
West Germany  87  8  17  0  24  16  5  10 
East Germany  89  8  18  0  21  14  7  17 
Total 87  8  17  0  23  16  5  11 
Note: based on all enterprises with any type of innovation activity during 2004 and 2006. 
A: Cash flow  B: New equity  C: Shareholder’s loan  D:  Bonds,  notes 
E: Overdraft credit  F: Bank loan  G: Public loan  H: Public subsidy 




Determinants of financing innovation through cash flow, bank loans and public 
subsidies: results of probity models for German enterprises 
 
Cash Flow  Bank Loans  Public Subsidies 
  m.E.  t value  m.E.  t value  m.E.  t value 
Innovation  characteristics                
Continuous R&D activities   -0.010 
-




*  0.082 4.46 
**
* 
Incremental product innovation   0.028  1.69  *  -0.037 
-
1.65 *  0.060  2.07 ** 
Product range novelty  0.028  1.77  *  -0.014 
-
0.63     0.030  1.12    
Market novelty in establ. market  -0.009 
-
0.36     -0.035 
-
1.13     0.039  1.13    
Radical product innovation  0.034  2.18  **  -0.044 
-
2.14  ** 0.050  2.17 ** 
Incremental process innovation  0.033  1.42     0.029  0.82     0.015  0.46    
Quality process innovation   -0.017 
-
0.96     0.003  0.13     0.058  2.38 ** 
Efficiency process innovation   0.022  0.91     -0.045 
-
1.57     -0.020 
-
0.59    
Radical process innovation  -0.004 
-
0.29     0.021  1.05     0.018  0.87    
Capital exp. f. innovation 
(share)  -0.008 
-
0.68     0.016  0.91     0.161  1.38    
Financial resources                            




*  -0.042 
-
1.27    
Increase of equity ratio 2004-06  0.033  2.64 
**
*  0.034 1.99  **  -0.005 
-
0.30    
Decrease of equity ratio 2004-
06  0.005  0.31     0.056  2.01 ** 0.024  0.91    
Profit margin 0% - <4%, lagged  0.022  1.26     0.025  0.84     -0.031 
-
1.24    Management & Marketing 
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Cash Flow  Bank Loans  Public Subsidies 
  m.E.  t value  m.E.  t value  m.E.  t value 
Profit margin 4% - <10%, 
lagged  0.043 2.38 
**
*  0.053 1.71  *  -0.023 
-
0.92    
Profit margin ≥10%, lagged  0.056  3.06 
**
*  0.008 0.25      -0.051 
-
1.90  * 
Profit margin: missing value  0.055  2.83 
**
*  0.049 1.23      -0.029 
-
0.87    
Firm characteristics                            
ln(no. of employees)  0.020  4.47 
**
*  0.006 1.12      0.017 2.98 
**
* 
ln(age of the firm)  0.004  0.57     -0.015 
-




























Limited partnership  0.021  1.02     -0.061 
-
2.28 ** -0.033 
-
0.96    




*  0.014 0.47     
Incorporation 0.015  0.52      -0.012 
-
0.33   0.017 0.41     
East German firm  0.017  1.32     0.006  0.37     0.153  7.96 
**
* 
No. of observations  2,013  2,013  2,013 
Share of positive observations  0.90  0.16  0.18 
Pseudo R2 0.12  0.11  0.18 
Note: All models contain a set of industry dummies which are not shown due to space 
restrictions, coefficients of industry dummies are jointly significant. m.E.: marginal effect. 
Source: ZEW: German Innovation Survey 2007, calculations based on net sample. 